BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25687527)

  • 1. A fast Resazurin-based live viability assay is equivalent to the MTT-test in the KeratinoSens assay.
    Emter R; Natsch A
    Toxicol In Vitro; 2015 Jun; 29(4):688-93. PubMed ID: 25687527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells.
    Xu M; McCanna DJ; Sivak JG
    J Pharmacol Toxicol Methods; 2015; 71():1-7. PubMed ID: 25464019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events.
    Emter R; van der Veen JW; Adamson G; Ezendam J; van Loveren H; Natsch A
    Toxicol In Vitro; 2013 Dec; 27(8):2225-32. PubMed ID: 24055896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation.
    Natsch A; Ryan CA; Foertsch L; Emter R; Jaworska J; Gerberick F; Kern P
    J Appl Toxicol; 2013 Nov; 33(11):1337-52. PubMed ID: 23576290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin.
    Präbst K; Engelhardt H; Ringgeler S; Hübner H
    Methods Mol Biol; 2017; 1601():1-17. PubMed ID: 28470513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
    van Tonder A; Joubert AM; Cromarty AD
    BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three different cell viability assays for evaluation of vanadyl sulphate cytotoxicity in a Chinese hamster ovary K1 cell line.
    Zwolak I
    Toxicol Ind Health; 2016 Jun; 32(6):1013-25. PubMed ID: 25107459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays.
    Riss TL; Moravec RA
    Assay Drug Dev Technol; 2004 Feb; 2(1):51-62. PubMed ID: 15090210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment.
    Natsch A; Emter R; Gfeller H; Haupt T; Ellis G
    Toxicol Sci; 2015 Feb; 143(2):319-32. PubMed ID: 25338925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HPLC/UPLC-spectrophotometry for detection of formazan in in vitro Reconstructed human Tissue (RhT)-based test methods employing the MTT-reduction assay to expand their applicability to strongly coloured test chemicals.
    Alépée N; Barroso J; De Smedt A; De Wever B; Hibatallah J; Klaric M; Mewes KR; Millet M; Pfannenbecker U; Tailhardat M; Templier M; McNamee P
    Toxicol In Vitro; 2015 Jun; 29(4):741-61. PubMed ID: 25701760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
    Monteiro-Riviere NA; Inman AO; Zhang LW
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):222-35. PubMed ID: 18983864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro method for skin corrosion testing.
    Perkins MA; Osborne R; Johnson GR
    Fundam Appl Toxicol; 1996 May; 31(1):9-18. PubMed ID: 8998958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of a cultured human corneal epithelial tissue model for the determination of the ocular irritation potential of pharmaceutical process materials.
    Seaman CW; Whittingham A; Guest R; Warren N; Olson MJ; Guerriero FJ; Adriaens E; De Wever B
    Toxicol In Vitro; 2010 Sep; 24(6):1862-70. PubMed ID: 20227483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances.
    Tornier C; Amsellem C; Fraissinette Ade B; Alépée N
    Toxicol In Vitro; 2010 Feb; 24(1):245-56. PubMed ID: 19733227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation.
    Watanabe T; Hasegawa T; Takahashi H; Ishibashi T; Itagaki H; Sugibayashi K
    Pharm Res; 2002 May; 19(5):669-75. PubMed ID: 12069171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells.
    Boncler M; Różalski M; Krajewska U; Podsędek A; Watala C
    J Pharmacol Toxicol Methods; 2014; 69(1):9-16. PubMed ID: 24103906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test.
    Alépée N; Tornier C; Robert C; Amsellem C; Roux MH; Doucet O; Pachot J; Méloni M; de Brugerolle de Fraissinette A
    Toxicol In Vitro; 2010 Feb; 24(1):257-66. PubMed ID: 19733228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential in vitro epidermal equivalent assay to determine sensitizer potency.
    dos Santos GG; Spiekstra SW; Sampat-Sardjoepersad SC; Reinders J; Scheper RJ; Gibbs S
    Toxicol In Vitro; 2011 Feb; 25(1):347-57. PubMed ID: 20940038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs.
    Martin A; Morcillo N; Lemus D; Montoro E; Telles MA; Simboli N; Pontino M; Porras T; León C; Velasco M; Chacon L; Barrera L; Ritacco V; Portaels F; Palomino JC
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):901-6. PubMed ID: 16104638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.